 |
Driven by strategic vision and financial power, Clal Biotechnology Industries Ltd (CBI) is the largest biotechnology investment group in Israel. CBI targets promising companies with innovative bio-pharma technologies and transforms them into thriving and productive businesses.
We are backed by Clal Industries & Investments Ltd., one of Israel's largest investment companies, and Teva Pharmaceutical Industries Ltd., the world's largest manufacturer of generic drugs - CBI successfully leverages a unique investment model of large-scale, long-term financial and managerial commitment to yield significant results and valued creation.
CBI is traded on the Tel-Aviv stock exchange (TASE: CBI). |
|